Pegargiminase Completed Phase 2 Trials for Hepatocellular,Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00056992Testing of ADI-PEG in Hepatocellular Carcinoma